Li L - Search Results

1

Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia.

Koeberl D, Schulze A, Sondheimer N, Lipshutz GS, Geberhiwot T, Li L, Saini R, Luo J, Sikirica V, Jin L, Liang M, Leuchars M, Grunewald S. Koeberl D, et al. Among authors: li l. Nature. 2024 Apr;628(8009):872-877. doi: 10.1038/s41586-024-07266-7. Epub 2024 Apr 3. Nature. 2024. PMID: 38570682 Free PMC article. Clinical Trial.

2

Author Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia.

Koeberl D, Schulze A, Sondheimer N, Lipshutz GS, Geberhiwot T, Li L, Saini R, Luo J, Sikirica V, Jin L, Liang M, Leuchars M, Grunewald S. Koeberl D, et al. Among authors: li l. Nature. 2024 May;629(8011):E10. doi: 10.1038/s41586-024-07413-0. Nature. 2024. PMID: 38649490 No abstract available.

3

Publisher Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia.

Koeberl D, Schulze A, Sondheimer N, Lipshutz GS, Geberhiwot T, Li L, Saini R, Luo J, Sikirica V, Jin L, Liang M, Leuchars M, Grunewald S. Koeberl D, et al. Among authors: li l. Nature. 2024 Jun;630(8017):E13. doi: 10.1038/s41586-024-07646-z. Nature. 2024. PMID: 38844679 Free PMC article. No abstract available.

4

Evaluating PAX1/JAM3 methylation for triage in HPV 16/18-infected women.

Fei J, Zhai L, Wang J, Zhu X, Liu P, Wang L, Ma D, Li L, Zhou J. Fei J, et al. Among authors: li l. Clin Epigenetics. 2024 Dec 26;16(1):190. doi: 10.1186/s13148-024-01804-w. Clin Epigenetics. 2024. PMID: 39726021

5

Factors associated with poor hip flexion range of motion after total hip arthroplasty in patients with ankylosing spondylitis: a retrospective study on 538 consecutive hips.

Li L, Fu J, Xu C, Ni M, Chai W, Hao L, Zhou Y, Chen J. Li L, et al. J Orthop Surg Res. 2024 Dec 26;19(1):877. doi: 10.1186/s13018-024-05318-2. J Orthop Surg Res. 2024. PMID: 39726010

6

Plasma biomarkers in patients with age-related sarcopenia: a proteomic exploration and experimental validation.

Lin Q, Li K, Li L, Guan L, Zeng Y, Cai D, Zhou J, Xu L. Lin Q, et al. Among authors: li l. Aging Clin Exp Res. 2024 Dec 27;37(1):13. doi: 10.1007/s40520-024-02903-7. Aging Clin Exp Res. 2024. PMID: 39725826

7

Advances of NAT10 in diseases: insights from dual properties as protein and RNA acetyltransferase.

Xiao B, Wu S, Tian Y, Huang W, Chen G, Luo D, Cai Y, Chen M, Zhang Y, Liu C, Zhao J, Li L. Xiao B, et al. Among authors: li l. Cell Biol Toxicol. 2024 Dec 27;41(1):17. doi: 10.1007/s10565-024-09962-6. Cell Biol Toxicol. 2024. PMID: 39725720 Review.

8

Therapeutic potential of microglial SMEK1 in regulating H3K9 lactylation in cerebral ischemia-reperfusion.

Si WY, Yang CL, Wei SL, Du T, Li LK, Dong J, Zhou Y, Li H, Zhang P, Liu QJ, Duan RS, Duan RN. Si WY, et al. Among authors: li lk. Commun Biol. 2024 Dec 26;7(1):1701. doi: 10.1038/s42003-024-07425-6. Commun Biol. 2024. PMID: 39725685

9

Detection and quantification of residual low-level HIV viremia in plasma based on extracellular particle co-isolation.

Zhou M, Deng K, Zheng X, Zhang Y, Yang Y, Li Y, Chen J, Zhong H, Cai W, Wang T, Li L. Zhou M, et al. Among authors: li l. Chin Med J (Engl). 2024 Oct 25. doi: 10.1097/CM9.0000000000003327. Online ahead of print. Chin Med J (Engl). 2024. PMID: 39725638 No abstract available.

10

[GSK484, a PAD4 inhibitor, improves endothelial dysfunction in mice with sepsis-induced lung injury by inhibiting H3Cit expression].

Su X, Li L, Dai J, Xiao B, Jin Z, Liu B. Su X, et al. Among authors: li l. Nan Fang Yi Ke Da Xue Xue Bao. 2024 Dec 20;44(12):2396-2403. doi: 10.12122/j.issn.1673-4254.2024.12.16. Nan Fang Yi Ke Da Xue Xue Bao. 2024. PMID: 39725629 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98,996 results

Search Page

Filters